THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIA

This publication has 21 references indexed in Scilit:

• Studies on the Biochemical Sequelae of Therapy in Thy-Acute Lymphoblastic Leukaemia with the Adenosine Deaminase Inhibitor 2’Deoxycoformycin
  British Journal of Haematology, 1981
• Prognostic Importance of Immunologic Markers in Adult Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 1981
• REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIA
  The Lancet, 1980
• CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
  The Lancet, 1980
• Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission
  New England Journal of Medicine, 1979
• Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations.
  Journal of Clinical Investigation, 1976
• SUCCESSFUL FETAL LIVER TRANSPLANTATION IN A CHILD WITH SEVERE COMBINED IMMUNODEFICIENCY
  The Lancet, 1975
• Combined immunodeficiency disease associated with adenosine deaminase deficiency: Report on a Workshop Held in Albany, New York, October 1, 1973
  The Journal of Pediatrics, 1975
• A novel adenosine and ara‐a deaminase inhibitor, (R)‐3‐(2‐deoxy‐β‐D‐erythro‐pentofuranosyl)‐3,6,7,8‐tetrahydroimidazo[4,5 ‐d] [1,3]diazepin‐8‐ol
  Journal of Heterocyclic Chemistry, 1974
• ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITY
  The Lancet, 1972